Showing results (871-880 of 14,088) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|October 20, 1999
The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell linesT Y Ng, H Y Ngan, D K Cheng, et al.Gynecologic Oncology|October 20, 1999
Repetitive hydatidiform mole with different male partnersZ S Tuncer, M R Bernstein, J Wang, et al.Gynecologic Oncology|October 20, 1999
Recurrent squamous cell carcinoma of the Bartholin's duct treated with en bloc resectionL R Nycum, J H Farley, M E Reed, et al.Gynecologic Oncology|September 10, 1999
A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancerP Ritvo, G Robinson, J Irvine, et al.Gynecologic Oncology|September 10, 1999
Prognostic significance of DNA ploidy in endometrial cancerD M Larson, R Berg, G Shaw, et al.Gynecologic Oncology|September 10, 1999
Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervixA Maitra, I I Wistuba, D Gibbons, et al.Gynecologic Oncology|September 10, 1999
Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomasC A Rainho, A Pontes, S R RogattoGynecologic Oncology|September 10, 1999
Reporting normal endometrial cells in Pap smears: an outcome appraisalC R Gomez-Fernandez, P Ganjei-Azar, J Capote-Dishaw, et al.Gynecologic Oncology|September 10, 1999
Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervixA Covens, J Kirby, P Shaw, et al.Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.Pageof 1,409